A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 388 participants.
Also called NCT05478252
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 388 participants
- Sponsor
- Registry
-
NCT05478252 -
2021-001501-69
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Poland, Slovakia, South Africa
- Registry status
- Completed
Technical summary
Registry record NCT05478252. Randomized; triple masking; primary purpose treatment. Start 2022-08-03 (actual); primary completion 2023-08-09 (actual). Results posted on 2024-10-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Semaglutide J
- Intervention (Drug)
- Semaglutide B
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct05478252- Content hash
900474fb6035993f578f57714ffe514d3224ad2ed09cdbc552f491fb95982a37